Pharmaceuticals, Biotechnology and Life Sciences
LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of their latest success story on…
First results from the expansion part of the Company’s phase I trial, evaluating the potential of first-in-class NBTXR3 to improve…
BERLIN–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by…
DUISBURG, Germany–(BUSINESS WIRE)–Genekam Biotechnology AG, Germany has developed a plasma therapy accelerator called SARS-Hunter, which gives possibility to hospitals to…
RALEIGH, N.C.–(BUSINESS WIRE)–#chaperoneprotein–Arrevus Inc. (www.arrevus.com), a biotechnology company focused on developing novel therapeutics for orphan or serious indications, received two…
SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…
Intended for U.S. Media Only 71 percent overall response rate (ORR) per investigator assessment and median duration of response of…
— Peer-reviewed publication in Alzheimer’s & Dementia: Translational Research & Clinical Interventions validates potential of drug discovery platform and ability…
-Combination of Rebastinib and Paclitaxel Demonstrates Encouraging Anti-tumor Activity and Favorable Tolerability in Patients with Advanced Endometrial Cancer- WALTHAM, Mass.–(BUSINESS…
Data from Phase 1 Trial of RGX-202 Presented at 2020 ASCO Virtual Scientific Program NEW YORK–(BUSINESS WIRE)–#biotech–RGENIX, Inc., a clinical…